Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 2, Issue 12 (2014)

Correction of lipid and purine metabolism in patients with arterial hypertension, obesity and gout

Author(s):
Maryana Vatseba
Abstract:
Our study aimed to evaluate the methods of correction of lipid and purine metabolism in patients with hypertension combined with obesity and gout. The study involved 46 patients with hypertension, gout and obesity. The aim of research was to improve treatment of patients with hypertension, gout and obesity by using Losartan and Meldonium. Application to the basic therapy Losartan and Meldonium improves lipid profile and reduces the level of uric acid. Thus, the combined use of Losartan and Meldonium is feasible, effective and safe for prolonged use.
Pages: 20-23  |  612 Views  4 Downloads
How to cite this article:
Maryana Vatseba. Correction of lipid and purine metabolism in patients with arterial hypertension, obesity and gout. 2014; 2(12): 20-23.
Journals List Click Here Research Journals Research Journals
Call for book chapter